Dr Stephen L Phillips, MD | |
1790-64b East Market St, Harrisonburg, VA 22801 | |
(540) 564-5622 | |
(757) 579-8594 |
Full Name | Dr Stephen L Phillips |
---|---|
Gender | Male |
Speciality | Preventive Medicine - Occupational Medicine |
Location | 1790-64b East Market St, Harrisonburg, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538123401 | NPI | - | NPPES |
1538123401 | Medicaid | VA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 0101032372 (Virginia) | Secondary |
2083X0100X | Preventive Medicine - Occupational Medicine | 0101032372 (Virginia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Stephen L Phillips, MD Po Box 1430, Harrisonburg, VA 22803-1430 Ph: (540) 564-5644 | Dr Stephen L Phillips, MD 1790-64b East Market St, Harrisonburg, VA 22801 Ph: (540) 564-5622 |
News Archive
Adolescent girls and young women in Mombasa, Kenya are more likely to experience higher risks of HIV and gender-based violence when they are involved with sex work venues or have sexual experiences at a young age, suggests a study co-led by St. Michael's Hospital and the University of Manitoba in Canada.
It's widely accepted that people watching an expert golfer or carpenter can learn the procedural steps to a better golf swing or building a deck. However, researchers Andrew A.G. Mattar at McGill University and Paul L. Gribble of the University of Western Ontario have developed startling evidence that people can unconsciously learn complex motor behaviors by watching such performances.
A genetic variant that is particularly prevalent in people of African ancestry confers protection against malaria. LMU researchers have now shown how it modulates the properties of white blood cells that play a major role in immune defenses and inflammation.
The American Association of Diabetes Educators (AADE) today released new guidance and supporting resources to help healthcare professionals engage in care that is tailored to an individual's needs.
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today it has initiated its ATHENA natural history of disease study in patients with Alport syndrome, a life-threatening genetic kidney disease with no approved therapy.
› Verified 8 days ago